ADC Therapeutics
Amy O'Mahoney is a seasoned healthcare sales professional with extensive experience in oncology and hematology. Currently serving as a Hematology Therapeutic Specialist at ADC Therapeutics since April 2024, Amy previously excelled as an Oncology Sales Manager at MorphoSys and as a Senior Oncology Account Manager at Seagen. Past roles include Executive Oncology Specialist at Merck and Immuno-Oncology Sales Specialist at Bristol-Myers Squibb, where significant contributions were made to the launch of immuno-oncology treatments. Amy has also held leadership positions in virology at various companies, achieving multiple awards for performance and leadership excellence. An alumna of Manhattan University with a Bachelor's degree in Marketing and Psychology, Amy combines clinical knowledge with strategic marketing expertise to drive sales and foster client relationships in the healthcare industry.
This person is not in any teams
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.